267 related articles for article (PubMed ID: 17684154)
1. CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.
Damle RN; Temburni S; Calissano C; Yancopoulos S; Banapour T; Sison C; Allen SL; Rai KR; Chiorazzi N
Blood; 2007 Nov; 110(9):3352-9. PubMed ID: 17684154
[TBL] [Abstract][Full Text] [Related]
2. In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia.
Calissano C; Damle RN; Hayes G; Murphy EJ; Hellerstein MK; Moreno C; Sison C; Kaufman MS; Kolitz JE; Allen SL; Rai KR; Chiorazzi N
Blood; 2009 Nov; 114(23):4832-42. PubMed ID: 19789386
[TBL] [Abstract][Full Text] [Related]
3. The activity of atorvastatin and rosiglitazone on CD38, ZAP70 and apoptosis in lymphocytes of B-cell chronic lymphocytic leukemia in vitro.
Yavasoglu I; Sargin G; Kadikoylu G; Karul A; Bolaman Z
Med Oncol; 2013; 30(3):603. PubMed ID: 23686733
[TBL] [Abstract][Full Text] [Related]
4. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
[TBL] [Abstract][Full Text] [Related]
5. Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.
Brachtl G; Sahakyan K; Denk U; Girbl T; Alinger B; Hofbauer SW; Neureiter D; Hofbauer JP; Egle A; Greil R; Hartmann TN
PLoS One; 2011; 6(8):e23758. PubMed ID: 21876768
[TBL] [Abstract][Full Text] [Related]
6. THE PROGNOSTIC SIGNIFICANCE OF COMBAIND EXPRESSION OF ZAP-70 AND CD38 IN CHRONIC LYMPHOCYTIC LEUKEMIA.
Kirtava T; Vatsadze T; Azrmaiparashili E; Ghirdaladze D
Georgian Med News; 2017 Jun; (267):12-16. PubMed ID: 28726646
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia.
Hus I; Podhorecka M; Bojarska-Junak A; Roliński J; Schmitt M; Sieklucka M; Wasik-Szczepanek E; Dmoszyńska A
Ann Oncol; 2006 Apr; 17(4):683-90. PubMed ID: 16524977
[TBL] [Abstract][Full Text] [Related]
8. CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential.
Deaglio S; Vaisitti T; Aydin S; Bergui L; D'Arena G; Bonello L; Omedé P; Scatolini M; Jaksic O; Chiorino G; Efremov D; Malavasi F
Blood; 2007 Dec; 110(12):4012-21. PubMed ID: 17699742
[TBL] [Abstract][Full Text] [Related]
9. Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70/CD38 expression in B-cell chronic lymphocytic leukemia.
Guillaume N; Gouilleux-Gruart V; Claisse JF; Troussard X; Lepelley P; Damaj G; Royer B; Garidi R; Lefrere JJ
Leuk Lymphoma; 2007 Aug; 48(8):1556-60. PubMed ID: 17701587
[TBL] [Abstract][Full Text] [Related]
10. In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.
Deaglio S; Vaisitti T; Aydin S; Ferrero E; Malavasi F
Blood; 2006 Aug; 108(4):1135-44. PubMed ID: 16621959
[TBL] [Abstract][Full Text] [Related]
11. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Gooden CE; Jones P; Bates R; Shallenberger WM; Surti U; Swerdlow SH; Roth CG
Cytometry B Clin Cytom; 2018 Jan; 94(1):129-135. PubMed ID: 27221715
[TBL] [Abstract][Full Text] [Related]
12. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
[TBL] [Abstract][Full Text] [Related]
13. [Expression of CLLU1 in patients with chronic lymphocytic leukemia and its prognostic significance].
Chen LJ; Zheng WJ; Wu YJ; Li L; Qian SX; Xu W; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):737-40. PubMed ID: 18457263
[TBL] [Abstract][Full Text] [Related]
14. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis.
Zupo S; Isnardi L; Megna M; Massara R; Malavasi F; Dono M; Cosulich E; Ferrarini M
Blood; 1996 Aug; 88(4):1365-74. PubMed ID: 8695855
[TBL] [Abstract][Full Text] [Related]
15. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
16. Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4.
Willimott S; Baou M; Huf S; Deaglio S; Wagner SD
Haematologica; 2007 Oct; 92(10):1359-66. PubMed ID: 18024373
[TBL] [Abstract][Full Text] [Related]
17. Zeta-associated protein 70 expression in chronic lymphocytic leukemia: Relevance in Indian context.
Gupta R; Garg N; Singh A; Jain SL
Indian J Pathol Microbiol; 2023; 66(2):291-294. PubMed ID: 37077070
[TBL] [Abstract][Full Text] [Related]
18. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.
Rassenti LZ; Jain S; Keating MJ; Wierda WG; Grever MR; Byrd JC; Kay NE; Brown JR; Gribben JG; Neuberg DS; He F; Greaves AW; Rai KR; Kipps TJ
Blood; 2008 Sep; 112(5):1923-30. PubMed ID: 18577710
[TBL] [Abstract][Full Text] [Related]
19. FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.
Li FJ; Ding S; Pan J; Shakhmatov MA; Kashentseva E; Wu J; Li Y; Soong SJ; Chiorazzi N; Davis RS
Blood; 2008 Jul; 112(1):179-87. PubMed ID: 18314442
[TBL] [Abstract][Full Text] [Related]
20. Elevated IL-17A and IL-22 regulate expression of inducible CD38 and Zap-70 in chronic lymphocytic leukemia.
Kouzegaran S; Siroosbakht S; Farsad BF; Rezakhaniha B; Dormanesh B; Behnod V; Tanha AS
Cytometry B Clin Cytom; 2018 Jan; 94(1):143-147. PubMed ID: 27718514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
